spacer.png, 0 kB
spacer.png, 0 kB
 
 
New Anti-Anxiety Drug Starts a Clinical Phase II in Generalized Anxiety Disorders E-mail
Written by Administrator   
Abiogen Pharma today announced the start of a Phase II clinical trial in Vienna (Austria) in patients affected by GAD with ABIO 08/01, a new anti-anxiety drug. (full story )
 
< Prev   Next >
Related Resources
spacer.png, 0 kB
spacer.png, 0 kB

Attack Panic is a resource for panic and anxiety disorders. Information on these pages is (C) AttackPanic.com. Disclaimer.